Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.